Hutchmed China Ltd ADR (HCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 12-2022 | 06-2022 | 12-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 169,468 | -360,386 | -162,872 | -167,041 | -99,340 |
| Depreciation Amortization | 3,812 | 8,664 | 4,376 | 7,190 | 3,522 |
| Other Working Capital | 60,626 | 58,704 | 57,778 | 32,458 | 10,989 |
| Other Operating Activity | -7,503 | 24,419 | 10,859 | -76,830 | 13,510 |
| Operating Cash Flow | $226,403 | $-268,599 | $-89,859 | $-204,223 | $-71,319 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24,359 | -36,664 | -15,754 | -16,756 | -8,914 |
| Other Investing Activity | -291,598 | 333,252 | 275,460 | -289,564 | -146,974 |
| Investing Cash Flow | $-315,957 | $296,588 | $259,706 | $-306,320 | $-155,888 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 5,830 | -82,763 | -74,638 | 650,028 | 578,331 |
| Financing Cash Flow | $5,830 | $-82,763 | $-74,638 | $650,028 | $578,331 |
| Exchange Rate Effect | -6,558 | -9,490 | -5,249 | 2,427 | 687 |
| Beginning Cash Position | 313,278 | 377,542 | 377,542 | 235,630 | 235,630 |
| End Cash Position | 222,996 | 313,278 | 467,502 | 377,542 | 587,441 |
| Net Cash Flow | $-90,282 | $-64,264 | $89,960 | $141,912 | $351,811 |
| Free Cash Flow | |||||
| Operating Cash Flow | 226,403 | -268,599 | -89,859 | -204,223 | -71,319 |
| Free Cash Flow | 226,403 | -268,599 | -89,859 | -204,223 | -71,319 |